Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry
Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE
Speaker:
Assistant Professor C. Abi Khalil (Doha, QA)
Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure
Speaker:
Associate Professor T. Ichiki (Rochester, US)